Non-viral chimeric antigen receptor (CAR) T cells going viral
Chimeric antigen receptor (CAR) T cell therapy has made significant strides in the treatment of B-cell malignancies, but its application in treating solid tumors still poses significant challenges. Particularly, the widespread use of viral vectors to deliver CAR transgenes into T cells comes with li...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Immuno-Oncology and Technology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590018823000035 |